U.S. Industrials Stock News

The United States market has experienced a robust performance, rising 3.5% over the last week and climbing 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, identifying promising small-cap stocks can be key to unlocking potential opportunities that may not yet be fully recognized by the broader market.

Over the last 7 days, the United States market has risen by 3.5%, contributing to a substantial 31% increase over the past year, with earnings anticipated to grow by 16% annually in the coming years. In this thriving market environment, identifying strong dividend stocks can be crucial for investors seeking steady income and potential capital appreciation.

Despite the fact that Lightbridge Corporation (NASDAQ:LTBR) stock rose 13% last week, insiders who sold US$832k worth...

CEVA, Inc. ( NASDAQ:CEVA ), might not be a large cap stock, but it saw a decent share price growth of 14% on the...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Kimbell Royalty Partners (KRP) is back on investor radars after quarterly earnings topped analyst expectations, recent analyst upgrades, and a newly announced US$100 million unit buyback program that has focused attention on its cash return approach. See our latest analysis for Kimbell Royalty Partners. The recent 4.31% 1 day share price return, together with a 26.59% 90 day share price return and 37.43% 1 year total shareholder return, points to momentum building as investors react to...

Community Financial System (CBU) recently reported fourth quarter 2025 results, with operating EPS of US$1.12 coming in slightly below analyst expectations. Revenue of US$215.45 million came in ahead of forecasts. At the same time, the company extended its dividend track record, raising its payout for a 28th consecutive year. This combination of mixed earnings and ongoing shareholder returns is something many investors are weighing as they reassess the stock. See our latest analysis for...

Assessing recent moves in Farmers National Banc (FMNB) Farmers National Banc (FMNB) has drawn fresh attention after recent trading, with the share price at $13.41 and returns of 0.1% over the past day and about 2.4% over the past week. Over the past month the stock shows a return of about 7%, while the past 3 months reflect a slight 0.7% decline, prompting investors to reassess the regional bank's income profile and valuation. See our latest analysis for Farmers National Banc. Set against a...

Driven Brands Holdings has disclosed widespread accounting errors and material weaknesses in its internal controls, prompting plans to restate at least two years of financial statements and triggering multiple securities fraud class action lawsuits filed on behalf of shareholders. These revelations have not only raised serious questions about the reliability of past financial reporting, but also put corporate governance, capital allocation decisions, and management oversight under intense...

Oculis Holding (NasdaqGM:OCS) is back in focus after the European Medicines Agency granted PRIME designation to its neuroprotective candidate Privosegtor for optic neuritis, following earlier FDA Breakthrough Therapy and Orphan Drug recognitions. See our latest analysis for Oculis Holding. The EMA PRIME decision arrives after earlier FDA designations and comes at a time when Oculis Holding’s share price has a 90 day return of 27.42% and a 1 year total shareholder return of 85.32%. This...

The Morning Bull - US Market Morning Update Monday, Apr, 6 2026 US stock futures are pointing higher this morning, with E mini S&P 500 contracts up about 0.7% and Nasdaq 100 futures up just over 1%, as investors weigh a mix of strong jobs data and signs of cooling inflation. Nonfarm payrolls rose by 178,000 in March while unemployment sits at 4.3% and wage growth is 3.5% year on year, suggesting more people are working but pay pressures are easing. At the same time, the US Services PMI has...

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

In March 2026, the FDA issued a warning letter finding ImmunityBio’s TV ad and podcast for its bladder cancer drug Anktiva false or misleading, and multiple law firms have since launched securities class actions alleging investors were misled about the drug’s capabilities and promotional practices. At the same time, interim data from the pivotal QUILT‑2.005 trial led an independent committee to confirm that the completed 366‑patient study is adequately powered for a planned supplemental FDA...

Reddit (NYSE:RDDT) has approved a $1b share repurchase program, aiming to buy back its own stock over time. The company has also been fined £14.47m by the UK's Information Commissioner's Office for child data privacy violations. These developments come as Reddit's share price stands at $136.0 after a 9.6% gain over the past week and a 43.8% decline year to date. Reddit's recent moves present a mixed picture to consider. On one side, the $1b buyback signals that management is prepared to...

VICI Properties Inc. recently expanded its role in the One Beverly Hills project by providing a US$1.50 billion mezzanine loan behind a US$2.80 billion senior facility and agreed to acquire casino and hotel real estate in Alberta that will be folded into its existing triple-net master lease with PURE. Together, these moves deepen VICI’s exposure to high-end experiential real estate while extending long-term, inflation-linked rental streams from both U.S. luxury mixed-use and Canadian gaming...

If you are wondering whether JD.com's current share price offers value or just extra risk, this breakdown will help you make sense of where the stock stands today. JD.com closed at US$28.46, with returns of a 1.7% decline over 7 days, 5.3% over 30 days, a 3.6% decline year to date, a 16.1% decline over 1 year, a 24.7% decline over 3 years, and a 60.2% decline over 5 years, which may change how you think about its potential and risk. Recent coverage of JD.com has focused on its position in...

Baxter International (BAX) has launched its IV Verify Line Labeling System at the 2026 American Organization for Nursing Leadership Conference, highlighting a new automation tool aimed at IV line identification, medication safety, and nurse workflow efficiency. See our latest analysis for Baxter International. Despite the IV Verify launch highlighting Baxter International's focus on bedside safety and workflow tools, the shares trade at US$16.68 after a 5.6% 7 day share price gain but a 41.0%...

Terreno Realty (TRNO) has been drawing fresh attention after recent share moves, with the stock up about 2.5% over the past week but slightly lower over the past month. See our latest analysis for Terreno Realty. The recent 2.5% 7 day share price return sits alongside a 5.3% year to date share price return and a 20.5% 1 year total shareholder return, which suggests momentum is building rather than fading. If this kind of steady trend interests you, it could be a good moment to broaden your...

In early April 2026, Baron Capital reiterated its positive stance on Host Hotels & Resorts in its Q4 2025 fund letter, while the company also received Nareit’s 2026 Leader in the Light Award for Operations for large-cap REITs, recognizing its sustainability and operational practices. Together, the institutional endorsement and sustainability recognition underscore how Host links environmental and social initiatives with financial discipline, strengthening its appeal to long-term, ESG-focused...

We can readily understand why investors are attracted to unprofitable companies. Indeed, vTv Therapeutics ( NASDAQ:VTVT...

We can readily understand why investors are attracted to unprofitable companies. For example, although...

Onto Innovation recently reported that strong demand for its metrology and inspection tools in AI and advanced semiconductor packaging, supported by a record backlog and a major volume agreement with a leading HBM maker, is driving expectations for more than 30% revenue growth in advanced packaging in 2026. This momentum not only reinforces Onto Innovation’s role in critical AI and high‑bandwidth memory production, but also highlights how higher-margin advanced packaging tools and improving...

Procore Technologies (PCOR) has reshuffled its top leadership, naming Rachel Pyles as Chief Financial Officer and Walt Hearn as Chief Revenue Officer, while reaffirming its 2026 guidance and continued focus on AI driven platform expansion. See our latest analysis for Procore Technologies. The leadership reshuffle comes as the share price trades at US$58.02, with a 7 day share price return of 4.05% and a 90 day share price return showing a 22.14% decline, while the 3 year total shareholder...

In early April 2026, Alkermes plc announced it had begun the Brilliance phase 3 program, a set of randomized, double-blind, placebo-controlled studies testing its oral orexin 2 receptor agonist alixorexton in adults with narcolepsy type 1 and type 2, following earlier phase 1 and phase 2 work and Breakthrough Therapy designation in narcolepsy type 1. The launch of these Brilliance Studies signals Alkermes’ intention to build a differentiated sleep-disorder franchise around orexin agonism,...